PFOS Injury in HK-2 Cells: Ferroptosis and ER Stress

Study Background and Research Question

Perfluorooctane sulfonate (PFOS) is a persistent industrial chemical that can remain in the environment and accumulate in organisms. The kidney is relevant to PFOS toxicology because it participates in excretion, and prior studies have raised concerns about renal effects. Yet the cellular processes underlying PFOS-related kidney injury are not fully resolved. The study “Perfluorooctane sulfonate causes HK-2 cell injury through ferroptosis and endoplasmic reticulum stress pathways” addresses this question in HK-2 cells, a human proximal tubular epithelial cell model.

The authors focused on two stress responses with potential relevance to toxicant injury. Ferroptosis is an iron-dependent form of regulated cell death associated with lipid peroxidation and impaired antioxidant defenses. Endoplasmic reticulum stress arises when the ER’s protein-processing capacity is disrupted and can engage the unfolded protein response (UPR). The central question was whether PFOS exposure in HK-2 cells coincides with markers of renal tubular injury, ferroptosis, and ER stress. The study’s findings support the involvement of both stress pathways, but the measurements should be interpreted as evidence of pathway-associated changes rather than definitive proof that either pathway alone causes the injury.

Key Innovation from the Reference Study

The study’s contribution is its paired examination of ferroptosis-related readouts and ER stress-associated proteins in the same renal epithelial cell model. Rather than treating PFOS toxicity as a single oxidative-stress outcome, the authors assessed cellular iron, malondialdehyde (MDA), glutathione (GSH), and glutathione peroxidase 4 (GPX-4) alongside ER stress markers and kidney injury molecule-1 (KIM-1). This combination gives researchers a more integrated view of the response to PFOS in proximal tubular cells.

The reported pattern is biologically coherent with ferroptotic stress: intracellular total iron and MDA increased, while GSH and GPX-4 decreased. In parallel, KIM-1 and the ER stress-associated proteins GRP78, ATF6, IRE1, and PERK increased. These observations connect a renal injury marker with biochemical features associated with ferroptosis and an ER stress response. They do not, by themselves, establish whether ER stress precedes ferroptosis, whether ferroptosis drives ER stress, or whether both are parallel consequences of PFOS exposure. That distinction is important for designing the next experiments.

Methods and Experimental Design Insights

The investigators used HK-2 cells and included PFOS exposure at 200 μM, with ferrostatin-1 (Fer-1) at 1 μM in the experimental design, as described in the study abstract. They assessed cell viability and measured MDA, GSH, intracellular total iron, and GPX-4. KIM-1 was assessed as a marker of renal tubular injury, while GRP78, ATF6, IRE1, and PERK were measured as ER stress-related proteins. The published study is the source for these reported conditions and measured endpoints.

These endpoints are useful as a panel because they span cell outcome, lipid oxidation, iron balance, antioxidant capacity, injury, and ER stress. However, individual markers are not pathway-specific proof. For example, MDA is a lipid peroxidation-associated readout but does not identify the oxidized lipid species or establish ferroptosis on its own. Likewise, changes in total protein abundance for UPR-associated factors do not necessarily reveal their activation state, localization, or downstream transcriptional activity.

Protocol Parameters

• PFOS exposure reported: 200 μM in HK-2 cells; the abstract does not specify exposure duration, so it should not be inferred from this summary.
• Fer-1 condition reported: 1 μM ferrostatin-1 was included in the study design. The abstract summary available here does not detail the treatment sequence or provide a separate quantitative rescue result.
• Reported assay domains: cell viability; MDA, GSH, intracellular total iron, and GPX-4; KIM-1; and ER stress-associated GRP78, ATF6, IRE1, and PERK.
• Workflow consideration: For replication or extension, establish exposure timing and dose-response conditions in the target cell system, and include matched vehicle and untreated controls. These are design recommendations, not additional parameters reported by the paper.
• Interpretation consideration: A pathway claim is stronger when multiple orthogonal readouts and perturbations agree; protein abundance measurements alone do not resolve pathway activity or causal order.

Core Findings and Why They Matter

PFOS exposure was associated with increased KIM-1 expression, consistent with a renal tubular injury response. The authors also reported higher intracellular total iron and MDA, together with lower GSH and GPX-4. In combination, these changes align with conditions that can favor iron-dependent lipid damage: increased iron availability and lipid peroxidation occur alongside reduced antioxidant capacity. This pattern supports investigating ferroptosis in PFOS-associated tubular cell injury, while not excluding other forms of cellular damage.

At the same time, GRP78, ATF6, IRE1, and PERK expression increased. These proteins are associated with the ER stress response and its UPR signaling arms. Their elevation suggests that PFOS-treated HK-2 cells experience an ER stress-related response in addition to the ferroptosis-associated biochemical changes. The study therefore frames an endoplasmic reticulum stress pathway as part of the cellular response to PFOS, rather than presenting ferroptosis as an isolated event.

The practical significance is the set of testable questions the findings raise. Does reducing ER stress lessen the ferroptosis-associated changes, or does blocking ferroptosis alter ER stress markers? Do these responses depend on PFOS dose or exposure time? Answering these questions requires intervention experiments and appropriately selected functional readouts. The results are relevant to ER stress alleviation research and to broader cell-injury studies, but the paper does not report testing 4-PBA, apoptosis, or autophagic cell death. Those topics should be treated as possible follow-up directions, not as conclusions of this study.

For example, a chemical chaperone such as 4-Phenylbutyric acid (4-PBA) could be considered in a separate experiment to probe whether modulating ER protein-folding stress changes PFOS-associated outcomes. Such an experiment would need controls and complementary ferroptosis readouts; a change after 4-PBA treatment would not, by itself, prove that ER stress is the initiating mechanism. Similarly, apoptosis research or studies of autophagic cell death modulation would require dedicated assays because the reported work centers on ferroptosis-associated and ER stress-associated measurements.

Comparison with Existing Internal Articles

Two related internal resources provide broader context for researchers thinking about chemical chaperones and stress-pathway experiments. “4-Phenylbutyric Acid: Unraveling ER Stress and Ferroptosis” discusses the conceptual intersection of ER stress and ferroptosis. That topic overlaps with the pathways examined here, but the PFOS study supplies the direct HK-2 observations; the internal article should not be read as evidence that 4-PBA was tested in those experiments. “4-Phenylbutyric Acid: Strategic Insights for ER Stress Research” offers a wider discussion of ER stress applications. It may help frame follow-up study design, while the reference paper remains the source for PFOS exposure conditions and kidney-cell findings.

Limitations and Transferability

The principal limitation is the use of an in vitro cell model. HK-2 cells enable controlled study of proximal tubular responses, but they cannot reproduce whole-kidney exposure, interactions among renal cell types, systemic distribution, or organism-level clearance. The reported PFOS concentration is an experimental condition; it should not be equated directly with typical human exposure without exposure and dosimetry analyses.

The available study summary also does not provide exposure duration, detailed dose-response results, effect sizes, or the full sequence of Fer-1 treatment. Although Fer-1 was included in the design, the summarized results do not specify its effects. Consequently, the findings support a relationship between PFOS exposure and ferroptosis-associated and ER stress-associated changes, but they do not establish the degree to which either pathway is necessary for injury. Nor do the reported protein abundance changes alone establish activation of each UPR branch.

Further work could strengthen causal interpretation by defining time and concentration responses, testing pathway-directed interventions, and measuring functional outcomes alongside molecular markers. Replication in additional renal models and validation in appropriate in vivo systems would be needed before extending the conclusions to human kidney risk. The study is most useful as a mechanistic starting point: it identifies linked cellular responses that warrant targeted testing, rather than resolving their order or clinical significance.

Research Support Resources

For follow-up experiments that investigate chemical-chaperone approaches to ER stress, researchers can use 4-Phenylbutyric acid (4-PBA, SKU C6831) to support similar workflows. It is a research reagent for experimental pathway modulation and was not a treatment tested in the PFOS study.